James J. Dignam to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications James J. Dignam has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.100
-
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20; 370(8):699-708.
Score: 0.081
-
Integrated phase II/III clinical trials in oncology: a case study. Clin Trials. 2012 Dec; 9(6):741-7.
Score: 0.019